Supplementary Figure S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer Somaieh Hedayat , Luciano Cascione , David Cunningham , Marta Schirripa , Andrea Lampis , Jens C. Hahne , Nina Tunariu , Sung Pil Hong , Silvia Marchetti , Khurum Khan , Elisa Fontana , Valentina Angerilli , Mia Delrieux , Daniel Nava Rodrigues , Letizia Procaccio , Sheela Rao , David Watkins , Naureen Starling , Ian Chau , Chiara Braconi , Nicos Fotiadis , Ruwaida Begum , Naomy Guppy , Louise Howell , Melanie Valenti , Scott Cribbes , Bernadett Kolozsvari , Vladimir Kirkin , Sara Lonardi , Michele Ghidini , Rodolfo Passalacqua , Raghad Elghadi , Luca Magnani , David J. Pinato , Federica Di Maggio , Filippo Ghelardi , Elisa Sottotetti , Guglielmo Vetere , Paolo Ciracì , Georgios Vlachogiannis , Filippo Pietrantonio , Chiara Cremolini , Alessio Cortellini , Fotios Loupakis , Matteo Fassan , Nicola Valeri crossref（2024）
摘要
Supplementary Figure S1. Bio-speciment collection, MIR652-3p expression and clinical correlates in the PROSPECT-R and validation cohorts
更多 查看译文
AI 理解论文
溯源树
样例
